Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) and Sana Biotechnology (NASDAQ:SANA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations. Institutional & Insider Ownership 18.1% of Kyverna […]